Axxam S.p.A

Axxam S.p.A. is a privately owned contract research and discovery company located at Openzone Science Park, Bresso (Milan, Italy), with chemistry laboratories located in Naples (Italy) and business development offices in Europe, US and Japan.
Since its inception in 2001, as a spin-off from the Bayer Group, Axxam has supported the discovery programs of its clients by providing excellent quality discovery services carried out by highly engaged experts, complemented by the pharmaceutical industry experience from both, the management as well as the scientist teams.
Our capabilities and expertise include
. Molecular biology (cloning, gene expression analysis, protein expression, genomic engineering)
• Assay development and reagent provision (cellular and biochemical systems)
• Compound management
• Fully automated High-Throughput Screening (various read-outs including also radiometric formats)
• Fully automated High Content Screening and imaging
• Hit characterization & profiling
• Access to the AXXDIV2.0 compound collection (around 240,000 compounds)
• Cardiac safety and liability profiling
• Electrophysiology
These capabilities paired with our discovery mentality have allowed us to successfully execute:
• Hit identification projects
• Hit-to-lead projects
• Lead optimization programs
We are guided by a truly collaborative mentality, based on transparent processes and open communication. We are providing resources, expertise in a broad range of target classes, know-how, but also a problem-solving attitude and passion for our work. Each customer is equally important to us and this has been recognized by more than 70% of our business being based on repeated contracts. Axxam’s customer base is distributed around the globe and represents companies active in Pharmaceutical, Crop protection, Animal health, Cosmetics and Nutrition.
Axxam is also engaged in developing novel innovative therapies for diseases with a high unmet medical need.




Employee Count Range: 


Company type: 

Privately Held

Founded year: 


Share this page